OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod to ...

A major new initiative aims to redefine human-based research models for greater understanding of disease and the acceleration of new medicines.The proposal will enable the development of advanced, ...

The global lidocaine market, valued at approximately USD 0.89 billion in 2023, is projected to expand at a compound annual growth rate (CAGR) of 5.26% over the forecast period from 2024 to 2032.

Identifying the symptoms can help you steer patients to solutions, including a wrist brace, steroid injections and, in ...

Neuropathic pain, a chronic condition resulting from nervous system lesions or diseases, remains a formidable clinical challenge due to its complex and ...

Nonartricular pain — particularly widespread NAP — was linked to worse physical, emotional, and social well-being among adults with early RA.

New research contributes valuable data that may help low-dose ketamine infusions become more widely accepted as a safe and ...

Modern pain epidemiology and neuroscience teach us that pain and suffering are not medical cause and personal effect, but ...

As a cold snap grips the UK this week - with even snowfall expected in parts of the country - a joint expert, has issued a ...

These three stories of perseverance and hope with acute pain can help you take the first step toward better care.

Skye says her consultant has since told her the infection was 'almost deadly' and that if she had been sent home that day, ...

Introduction Pain is a prevalent symptom in people living with dementia. Evidence shows that pain frequently remains unrecognised and untreated in this vulnerable population, leading to avoidable ...